IP Library Granted Patent US 9,914,747
Granted Patent B2
US 9,914,747 · App. 15/521,957 · Granted Mar 13, 2018

Extended betulinic acid analogs

Inventors: Jie Chen (Wallingford, CT); Yan Chen (Wallingford, CT); Nicholas A. Meanwell (Wallingford, CT); Alicia Regueiro-Ren (Wallingford, CT); Sing-Yuen Sit (Wallingford, CT); Jacob Swidorski (Wallingford, CT)
Assignee: ViiV HEALTHCARE UK (NO.5) LIMITED
C07J63/008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,914,747
App. No.
15/521,957
Granted
Mar 13, 2018
Kind
B2
Abstract

Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, betulinic acid derivatives that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formulas I and II: These compounds are useful for the treatment of HIV and AIDS.

Claims (8)

1. A compound selected from the group consisting of:

and pharmaceutically acceptable salts thereof.

2. A compound selected from the group consisting of:

and pharmaceutically acceptable salts thereof.

3. A composition which comprises one or more compounds as claimed in claim 2 , together with one or more pharmaceutically acceptable carriers, excipients, and/or diluents.

4. A composition which comprises one or more compounds as claimed in claim 1 , together with one or more pharmaceutically acceptable carriers, excipients, and/or diluents.

5. A method for inhibiting, ameliorating and/or healing a mammal infected with the HIV virus comprising administering to said mammal a compound as claimed in claim 2 , together with one or more pharmaceutically acceptable carriers, excipients, and/or diluents.

6. A method for inhibiting, ameliorating and/or healing a mammal infected with the HIV virus comprising administering to said mammal a compound as claimed in claim 2 , together with one or more pharmaceutically acceptable carriers, excipients, and/or diluents.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2017
From: SIT, SING-YUEN; CHEN, JIE; CHEN, YAN; SWIDORSKI, JACOB; REGUEIRO-REN, ALICIA; MEANWELL, NICHOLAS A.
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 042162/0983 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2017
From: BRISTOL-MYERS SQUIBB COMPANY
To: VIIV HEALTHCARE UK (NO.5) LIMITED
Reel/Frame 042163/0196 →
Continuity (2)
Provisional Application 62079957 · Nov 14, 2014
Related Publication 20170334945A1 · Nov 23, 2017